169 related articles for article (PubMed ID: 28562563)
1. Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China: A retrospective analysis.
Xie Y; Lv X; Luo C; Hu K; Gou Q; Xie K; Zheng H
Medicine (Baltimore); 2017 Jun; 96(22):e7048. PubMed ID: 28562563
[TBL] [Abstract][Full Text] [Related]
2. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
4. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
[TBL] [Abstract][Full Text] [Related]
5. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
[TBL] [Abstract][Full Text] [Related]
6. Surgery of the primary tumor does not improve survival in stage IV breast cancer.
Dominici L; Najita J; Hughes M; Niland J; Marcom P; Wong YN; Carter B; Javid S; Edge S; Burstein H; Golshan M
Breast Cancer Res Treat; 2011 Sep; 129(2):459-65. PubMed ID: 21713372
[TBL] [Abstract][Full Text] [Related]
7. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
[TBL] [Abstract][Full Text] [Related]
8. 10-Year Survival after Breast-Conserving Surgery Compared with Mastectomy in Louisiana Women with Early-Stage Breast Cancer: A Population-Based Study.
Chu QD; Hsieh MC; Lyons JM; Wu XC
J Am Coll Surg; 2021 Apr; 232(4):607-621. PubMed ID: 33301909
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
10. Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.
Lim SM; Kim JY; Park HS; Park S; Kim GM; Sohn J; Kim SI
Breast J; 2019 Sep; 25(5):908-915. PubMed ID: 31187565
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.
Lang JE; Tereffe W; Mitchell MP; Rao R; Feng L; Meric-Bernstam F; Bedrosian I; Kuerer HM; Hunt KK; Hortobagyi GN; Babiera GV
Ann Surg Oncol; 2013 Jun; 20(6):1893-9. PubMed ID: 23306905
[TBL] [Abstract][Full Text] [Related]
12. Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
Sun ZH; Chen C; Kuang XW; Song JL; Sun SR; Wang WX
Medicine (Baltimore); 2021 May; 100(18):e25880. PubMed ID: 33951002
[TBL] [Abstract][Full Text] [Related]
13. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
14. Metastatic breast cancer: Who benefits from surgery?
Marks CE; Thomas SM; Fayanju OM; DiLalla G; Sammons S; Hwang ES; Plichta JK
Am J Surg; 2022 Jan; 223(1):81-93. PubMed ID: 34325907
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
16. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
[TBL] [Abstract][Full Text] [Related]
17. Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
Kim HJ; Kang E; Kim JH; Kim SH; Kim YJ; Kim IA; Eom KY; Chae SM; Kang KM; Kim EK; Kim SW
Clin Breast Cancer; 2018 Oct; 18(5):e1037-e1044. PubMed ID: 29909259
[TBL] [Abstract][Full Text] [Related]
18. Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients.
Ly BH; Vlastos G; Rapiti E; Vinh-Hung V; Nguyen NP
Tumori; 2010; 96(6):947-54. PubMed ID: 21388057
[TBL] [Abstract][Full Text] [Related]
19. Diminished survival in patients with inner versus outer quadrant breast cancers.
Gaffney DK; Tsodikov A; Wiggins CL
J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
[TBL] [Abstract][Full Text] [Related]
20. Identifying factors that impact survival among women with inflammatory breast cancer.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]